Research Topic · Peer-Reviewed

Corticosteroids for Covid-19

Corticosteroids for COVID-19 refers to the use of glucocorticoid medications, such as dexamethasone and related agents, to suppress excessive inflammation in patients with disease caused by SARS-CoV-2. Corticosteroids are synthetic analogues of adrenal hormones that exert broad anti-inflammatory and immunomodulatory…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 10× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed June 2026

Overview

Corticosteroids for COVID-19 refers to the use of glucocorticoid medications, such as dexamethasone and related agents, to suppress excessive inflammation in patients with disease caused by SARS-CoV-2. Corticosteroids are synthetic analogues of adrenal hormones that exert broad anti-inflammatory and immunomodulatory effects by altering the transcription of genes governing immune and inflammatory mediators, thereby dampening cytokine production and the recruitment of inflammatory cells. In COVID-19, severe illness is driven in part by a dysregulated host immune and inflammatory response that can injure the lungs and other organs, producing hypoxaemia and acute respiratory compromise. By attenuating this response, corticosteroids are used to reduce inflammatory lung injury in patients with more severe disease, particularly those requiring supplemental oxygen or respiratory support. Their benefit is closely tied to disease stage, since immunosuppression may be helpful during the hyperinflammatory phase but is generally not indicated in mild infection, where it could impair viral clearance. Use must also weigh adverse effects, including hyperglycaemia, secondary infection, and other complications of immunosuppression. Within coronavirus research, corticosteroids exemplify host-directed therapy that targets the immune response rather than the virus itself, and study in this area addresses indications, timing, dosing, and the balance of benefit and risk in management.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 5 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Corticosteroids for Covid-19, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.